文献速递脑血管病

CD47阻断抗体促进实验性脑出血血肿清除

Enhancement of Hematoma Clearance With CD47 Blocking Antibody in Experimental Intracerebral Hemorrhage.
PubMed 文献 · Stroke · 2019-05-14

该研究在小鼠自体血脑出血模型中检验CD47阻断抗体对血肿清除和脑损伤的作用。结果显示CD47阻断抗体加速男性小鼠血肿/铁清除、减轻脑肿胀和神经功能缺损,氯膦酸盐耗竭小胶质/巨噬细胞则加重损伤。雌性小鼠中CD47阻断抗体同样有效,提示其可能用于需手术清除血肿的脑出血患者。

要点

  • CD47阻断抗体可加速小鼠脑出血后血肿和铁的清除。
  • CD47阻断抗体减轻脑肿胀、神经元丢失和神经功能缺损。
  • 小胶质/巨噬细胞耗竭加重损伤,支持其介导清除作用。

核心结论

  • 阻断血肿内CD47可加速血肿清除并减轻实验性脑出血后的脑损伤。
  • CD47阻断抗体在雌性小鼠中同样有效。
  • 该策略可能成为需手术清除血肿的脑出血患者的治疗方法。

研究设计与样本

  • 研究为小鼠实验性研究,采用成年C57BL/6小鼠尾状核内注射自体血诱导脑出血。
  • 小鼠分组接受CD47阻断抗体或IgG共注射,部分CD47阻断抗体组共注射氯膦酸盐或对照脂质体。
  • 在雄性和雌性小鼠中均测试CD47阻断抗体对脑出血诱导脑损伤的效果,并用磁共振成像检查血凝块体积、铁沉积、脑肿胀和脑组织丢失。

主要发现

  • 在雄性小鼠中,CD47阻断抗体加速巨噬细胞/小胶质细胞对血肿/铁的清除,并减少脑出血诱导的脑肿胀、神经元丢失和神经功能缺损。
  • 氯膦酸盐脂质体诱导的小胶质/巨噬细胞耗竭导致更严重的脑肿胀、神经元丢失和功能缺损。
  • IgG对照组中雄性和雌性损伤严重程度相似,CD47阻断抗体在雌性中同样有效。

临床怎么用

  • CD47阻断抗体可能作为脑出血后促进血肿清除的潜在治疗策略。
  • 尤其可能适用于需手术清除血肿的脑出血患者。
  • 小胶质/巨噬细胞在血肿清除和减轻脑损伤中起重要作用。

局限性

  • 研究为小鼠实验性研究,结果尚未在人体中验证。
  • 血肿清除和脑损伤评估依赖动物模型,临床转化需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Our previous studies found that erythrocyte CD47 has a role in regulating hematoma resolution following experimental intracerebral hemorrhage (ICH). The current study examined whether or not a CD47 blocking antibody enhances hematoma clearance in a mouse ICH. Methods- ICH was induced by intracaudate injection of autologous blood in adult C57BL/6 mice. Mice had an ICH or ICH with CD47 blocking antibody or IgG coinjection. In subgroups of CD47 blocking antibody-treated mice, clodronate (to deplete microglia/macrophages) or control liposomes were coinjected. The effects of CD47 blocking antibody on ICH-induced brain injury were also tested in both males and females. Mice had magnetic resonance imaging to examine clot volume, iron deposition, brain swelling, and brain tissue loss. Behavioral tests were performed in all mice, and brains were harvested for brain immunohistochemistry. Results- In male mice, CD47 blocking antibody speeded up hematoma/iron clearance by macrophages/microglia and reduced ICH-induced brain swelling, neuronal loss, and neurological deficits. In contrast, clodronate liposome-induced microglia/macrophage depletion caused more severe brain swelling, neuronal loss, and functional deficits. In addition, similar injury severity in males and females was found in IgG control group and CD47 blocking antibody was also effective in females. Conclusions- Blocking CD47 in the hematoma speeded hematoma clearance and reduced brain injury after ICH suggesting it could be a treatment for ICH patients with surgical clot removal.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Jing C, Bian L, Wang M, et al. Enhancement of Hematoma Clearance With CD47 Blocking Antibody in Experimental Intracerebral Hemorrhage. Stroke. 2019. PMID: 31084334. doi:10.1161/STROKEAHA.118.024578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。